TORONTO—The Multiple Sclerosis Society of Canada is setting aside $1 million for a clinical trial of a controversial treatment in the event studies now underway determine the procedure shows promise in alleviating symptoms of the disease.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.